BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2695562)

  • 41. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
    Al-Jamal RT; Kivelä T
    Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body.
    Augsburger JJ; Gamel JW; Sardi VF; Greenberg RA; Shields JA; Brady LW
    Arch Ophthalmol; 1986 May; 104(5):655-61. PubMed ID: 3518677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered chromosome expression of uveal melanoma in the setting of melanocytosis.
    Horgan N; Shields CL; Swanson L; Teixeira LF; Eagle RC; Ganguly A; Shields JA
    Acta Ophthalmol; 2009 Aug; 87(5):578-80. PubMed ID: 18547285
    [No Abstract]   [Full Text] [Related]  

  • 44. Malignant nonteratoid medulloepithelioma of the ciliary body in an adult.
    Husain SE; Husain N; Boniuk M; Font RL
    Ophthalmology; 1998 Apr; 105(4):596-9. PubMed ID: 9544630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Internal eye wall resection of uveal tumors: long-term evaluation.
    Moreira CA; Moreira Neto CA
    Arq Bras Oftalmol; 2015; 78(1):47-9. PubMed ID: 25714539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Residual intrascleral and intraretinal melanoma: a concern with lamellar sclerouvectomy for uveal melanoma.
    Robertson DM; Campbell RJ; Weaver DT
    Am J Ophthalmol; 1991 Nov; 112(5):590-3. PubMed ID: 1951599
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
    Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
    Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Iridocyclectomy. A review. Gleanings from the literature.
    Vail DT
    Am J Ophthalmol; 1971 Jan; 71(1 Pt 2):161-8. PubMed ID: 5100463
    [No Abstract]   [Full Text] [Related]  

  • 49. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study.
    Rummelt V; Folberg R; Rummelt C; Gruman LM; Hwang T; Woolson RF; Yi H; Naumann GO
    Ophthalmology; 1994 Apr; 101(4):718-27. PubMed ID: 8152768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Long-term results after block excision].
    von Domarus D; Bujara K; Schewe AB
    Fortschr Ophthalmol; 1983; 80(4):315-7. PubMed ID: 6629258
    [No Abstract]   [Full Text] [Related]  

  • 51. Survival after primary enucleation of largest uveal melanomas.
    Gambrelle J; Kodjikian L; Grange JD
    Acta Ophthalmol Scand; 2005 Jun; 83(3):398; 398-9. PubMed ID: 15948802
    [No Abstract]   [Full Text] [Related]  

  • 52. [Trans-scleral resection of the ciliary body and choroidal melanoma].
    Romanowska-Dixon B; Starzycka M; Pogrzebielski A
    Klin Oczna; 2000; 102(5):323-6. PubMed ID: 11286105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Borderline spindle cell nevus of the ciliary body as a second primary melanoma--a clinicopathologic case.
    Kremer I; Ben-Sira I
    Ann Ophthalmol; 1989 Jun; 21(6):217-21. PubMed ID: 2764435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matched group study of preenucleation radiotherapy versus enucleation alone for primary malignant melanoma of the choroid and ciliary body.
    Augsburger JJ; Lauritzen K; Gamel JW; Lowry JC; Brady LW
    Am J Clin Oncol; 1990 Oct; 13(5):382-7. PubMed ID: 2220658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Surgical management of ciliary body melanoma].
    Romanowska-Dixon B
    Klin Oczna; 2005; 107(10-12):627-31. PubMed ID: 16619806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metastasis of malignant melanoma of the choroid and ciliary body to the contralateral choroid.
    Li J; Resnick K; Tso M
    Graefes Arch Clin Exp Ophthalmol; 1993 Sep; 231(9):546-53. PubMed ID: 8224960
    [No Abstract]   [Full Text] [Related]  

  • 57. Choroidal-ciliary body melanoma. A multivariate survival analysis of tumor location.
    McLean IW; Ainbinder DJ; Gamel JW; McCurdy JB
    Ophthalmology; 1995 Jul; 102(7):1060-4. PubMed ID: 9121753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of pre-enucleation radiotherapy on mitotic activity of choroidal and ciliary body melanomas.
    Augsburger JJ; Eagle RC; Chiu M; Shields JA
    Ophthalmology; 1987 Dec; 94(12):1627-30. PubMed ID: 3431833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative evaluation for patients with choroidal/ciliary body melanomas: what is necessary?
    Wykoff CC; Murray TG; Markoe AM; Feun LG; Schefler AC; Gayer S
    Am J Ophthalmol; 2011 Jun; 151(6):921-4. PubMed ID: 21616209
    [No Abstract]   [Full Text] [Related]  

  • 60. Prognostic factor study of survival after enucleation for juxtapapillary melanomas.
    Weinhaus RS; Seddon JM; Albert DM; Gragoudas ES; Robinson N
    Arch Ophthalmol; 1985 Nov; 103(11):1673-7. PubMed ID: 4062633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.